Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
[Preprint]. 2024 Aug 1:rs.3.rs-4669610.
doi: 10.21203/rs.3.rs-4669610/v1.

4-aminopyridine attenuates inflammation and apoptosis and increases angiogenesis to promote skin regeneration following a burn injury

Affiliations

4-aminopyridine attenuates inflammation and apoptosis and increases angiogenesis to promote skin regeneration following a burn injury

Prem Kumar Govindappa et al. Res Sq. .

Update in

Abstract

Severe thermal skin burns are complicated by inflammation and apoptosis, which delays wound healing and contributes to significant morbidity. Diverse treatments demonstrate limited success with mitigating these processes to accelerate healing. Agents that alter cell behavior to improve healing would alter treatment paradigms. We repurposed 4-aminopyridine (4-AP), a drug approved by the US FDA for multiple sclerosis, to treat severe burns. We found that 4-AP, in the early stages of burn healing, significantly reduced the expression of pro-inflammatory cytokines IL1β and TNFα while increasing the expression of anti-inflammatory markers CD206, ARG-1, and IL10. 4-AP attenuated apoptosis, with decreases in apoptotic markers BAX, caspase-9, and caspase-3 and increases in anti-apoptotic markers BCL2 and BCL-XL. Furthermore, 4-AP promoted angiogenesis through increases in the expression of CD31, VEGF, and eNOS. Together, these likely contributed to accelerated burn wound closure, as demonstrated in increased keratinocyte proliferation (K14) and differentiation (K10) markers. In the later stages of burn healing, 4-AP increased TGFβ and FGF levels, which are known to mark the transformation of fibroblasts to myofibroblasts. This was further demonstrated by an increased expression of α-SMA and vimentin, as well as higher levels of collagen I and III, MMP 3, and 9 in animals treated with 4-AP. Our findings support the idea that 4-AP may have a novel, clinically relevant therapeutic use in promoting burn wound healing.

PubMed Disclaimer

Conflict of interest statement

COMPETING INTERESTS PKG and JCE are inventors on patents 1). Methods and materials for treating burns (US18/139,123); (2). Methods and materials for treating hair loss (US18/270,914); 3). Methods and materials for treating nerve injury and/or promoting wound healing (US17/759,224) submitted by the Penn State Research Foundation. All other authors declare that they have no competing financial interests.

Figures

Figure 1
Figure 1. 4-AP expedited burn injury closure and enhanced skin regeneration.
A) Schematic illustration of experimental design to test the beneficial therapeutic effect of 4-AP in the C57BL/6 mouse burned model. B) Representative digital images of burn healing in saline and 4-AP (2 mg/kg/IP, single dose immediately after surgery and until day 21) treated mice at 0, 3, 5, 7, 10, 14, 18, and 21 days post-burning. Scale bar = 5 mm. C) Percent burn wound closure at each time point relative to the initial burn wound area in control and 4-AP-treated mice. n = 6 animals per group, with one burn wound per animal. D)Representative images of H&E-stained sections of full-thickness burn of saline and 4-AP treated skin tissue on days 3, 7, and 21. Scale bar = 100 μm, n =4 skin tissues per group. E) Quantification of burn wound length and area in H&E-stained skin burn sections using ImageJ software on days 3, 7, and 21. n = 4 skin tissues per group. Data are represented as mean ± SEM. The statistical significance is indicated by asterisks (*P < 0.05, and **P < 0.0021 vs. saline group) and compared using two-tailed, unpaired t-tests.
Figure 2
Figure 2. 4-AP attenuated pro-inflammation and accelerated anti-inflammatory effects following skin burn.
A and B) Representative images of IF staining of IL1β (pro-inflammatory) and CD206 (anti-inflammatory) and its quantitative results where 4-AP significantly controlled inflammatory resolution compared to saline-treated skin burn tissues on days 3 and 7. Scale bar = 100 μm. n = 4 skin tissues per group. C) qRT-PCR data shows that 4-AP treatment significantly attenuated pro-inflammatory genes (IL1β and TNFα; M1 macrophage markers) and upregulated anti-inflammatory genes (CD206, ARG-1, and IL10; M2 macrophage markers) compared to the saline group on days 3 and 7. n = 3 skin tissues per group. D and E) Western blotting images and quantitative results show that 4-AP treatment significantly attenuated IL1β and upregulated CD206 and ARG-1 protein expressions compared to the saline group on days 3 and 7. n = 3 skin tissues per group. Data are represented as mean ± SEM, and the statistical significance is indicated by asterisks (*P < 0.05 and **P < 0.0021 vs. saline group) and compared using two-tailed, unpaired t-tests.
Figure 3
Figure 3. 4-AP enhanced angiogenesis following skin burn.
A and B) Representative images and quantitative results of IF staining of CD31 in saline and 4-AP treated skin burn tissues on days 3 and 7. Scale bar = 100 μm. n = 4 skin tissues per group. C) qRT-PCR data shows that 4-AP treatment significantly increased the expression of angiogenesis genes (VEGF, CD31, and eNOS) compared to the saline group on days 3 and 7. n = 3 skin tissues per group. D and E) Western blotting images and quantitative results showed that 4-AP treatment significantly increased angiogenesis protein expressions (VEGF, CD31, and eNOS) compared to the saline group on days 3 and 7. n = 3 skin tissues per group. Data are represented as mean ± SEM. The statistical significance is indicated by asterisks (*P < 0.05, **P < 0.0021, and ***P < 0.0002 vs. saline group) and compared using two-tailed, unpaired t-tests.
Figure 4
Figure 4. 4-AP attenuated pro-apoptosis and accelerated anti-apoptosis effects following skin burn.
A and B) Representative images of DAB-TUNEL staining of apoptosis and quantitative results of TUNEL positive cells in saline and 4-AP treated skin burn tissues on days 3 and 7. n = 4 skin tissues per group. C)qRT-PCR data shows that 4-AP treatment significantly attenuated pro-apoptosis genes (BAX, caspase-9, and caspase-3) and upregulated anti-apoptosis genes (BCL2) compared to the saline group on days 3 and 7. n = 3 skin tissues per group. D and E) Western blotting images and quantitative results showed that 4-AP treatment significantly attenuated expressions of pro-apoptosis protein (BAX) and upregulated anti-apoptosis proteins (BCL2 and BCL-XL) as compared to the saline group on days 3 and 7. n = 3 skin tissues per group. Data are represented as mean ± SEM. The statistical significance is indicated by asterisks (*P < 0.05, **P < 0.0021, and ***P < 0.0002 vs. saline group) and compared using two-tailed, unpaired t-tests.
Figure 5
Figure 5. 4-AP accelerated epithelization and keratinocytes terminal differentiation following skin burn.
A and B) Representative images and quantitative results of IF staining of keratinocyte markers (K10; terminal differentiation and K14; proliferative) in saline and 4-AP treated skin burn tissues on days 3 and 7. Scale bar = 100 μm. n = 4 skin tissues per group. C and D) Western blotting and E) qRT-PCR quantitative results show that 4-AP treatment significantly increased keratin markers protein and gene (K10 and K14) expressions compared to the saline group on days 3 and 7. n = 3 skin tissues per group. Data are represented as mean ± SEM. The statistical significance is indicated by asterisks (*P < 0.05, **P < 0.0021, and ***P < 0.0002 vs. saline group) and compared using two-tailed, unpaired t-tests.
Figure 6
Figure 6. 4-AP increased fibroblast to myofibroblast transformation following skin burn.
A and B) Representative images and quantitative results of IF staining of vimentin (fibroblasts) and α-SMA (myofibroblasts) in saline and 4-AP treated skin burn tissues on days 3 and 7. Scale bar = 100 μm. n = 4 skin tissues per group. C) qRT-PCR data shows that 4-AP treatment significantly increased the expression of TGFβ, vimentin, α-SMA, and FGF genes compared to the saline group on days 7 and 21. n = 3 skin tissues per group. D and E) Western blotting images and quantitative results showed that 4-AP treatment significantly increased the expression of TGFβ, vimentin, and α-SMA proteins compared to the saline group on days 7 and 21. n = 3 skin tissues per group. Data are represented as mean ± SEM. The statistical significance is indicated by asterisks (*P < 0.05, **P < 0.0021, and ***P < 0.0002 vs. saline group) and compared using two-tailed, unpaired t-tests.
Figure 7
Figure 7. 4-AP advanced skin burns wound repair by increasing collagen and MMP expressions.
A and B) Representative images and quantitative results of Herovici staining of collagen III/I in saline and 4-AP treated skin burn tissues on days 7 and 21. n = 4 skin tissues per group. C) qRT-PCR data shows that 4-AP treatment significantly increased the expression of collagen-III/I and MM9/3 genes compared to the saline group on days 7 and 21. n = 3 skin tissues per group. D and E) Western blotting images and quantitative results showed that 4-AP treatment significantly increased collagen-III/I protein expressions compared to the saline group on day 21. n = 3 skin tissues per group. Data are represented as mean ± SEM. The statistical significance is indicated by asterisks (*P < 0.05, **P < 0.0021, and P*** < 0.0002 vs. saline group) and compared using two-tailed, unpaired t-tests.
Figure 8
Figure 8. Schematic illustration of early and late phases of skin burn healing.
4-AP expedites burn wound healing via controlling multi-cellular events of A) macrophage, B) apoptosis, C) angiogenesis, D)keratinocyte, and E) fibroblast. During the early phase (days 3 and 7) of burn wound healing, 4-AP significantly mitigates inflammation and apoptosis and enhances angiogenesis, keratin, and fibroblast differentiation. In the later phase (day 21), 4-AP promotes wound closure by accelerating keratinocyte differentiation and accelerating the remodeling of the ECM via stimulating fibroblast and collagen differentiation.

Similar articles

References

    1. Jeschke MG, van Baar ME, Choudhry MA, Chung KK, Gibran NS, Logsetty S. Burn injury. Nat Rev Dis Primers 2020; 6: 11. - PMC - PubMed
    1. Ivanko A, Garbuzov AE, Schoen JE, Kearns R, Phillips B, Murata E et al. The Burden of Burns: An Analysis of Public Health Measures. J Burn Care Res 2024;: irae053. - PubMed
    1. Ivanko A, Garbuzov A, Schoen JE, Kearns RD, Danos D, Murata E et al. 101 The Burden of Burns: An Analysis of Public Health Measures. Journal of Burn Care & Research 2024; 45: 82–82. - PubMed
    1. Schaefer TJ, Tannan SC. Thermal Burns. In: StatPearls. StatPearls Publishing: Treasure Island (FL), 2024. http://www.ncbi.nlm.nih.gov/books/NBK430773/ (accessed 18 Jun2024). - PubMed
    1. Warby R, Maani CV. Burn Classification. In: StatPearls. StatPearls Publishing: Treasure Island (FL), 2024. http://www.ncbi.nlm.nih.gov/books/NBK539773/ (accessed 18 Jun2024). - PubMed

Publication types

LinkOut - more resources